19,549 Shares in The Cooper Companies, Inc. $COO Purchased by Bank of Nova Scotia

Bank of Nova Scotia acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 19,549 shares of the medical device company’s stock, valued at approximately $1,402,000.

Several other hedge funds have also added to or reduced their stakes in the stock. Avalon Trust Co bought a new position in shares of Cooper Companies during the 2nd quarter valued at approximately $25,000. Root Financial Partners LLC raised its holdings in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares during the period. SJS Investment Consulting Inc. raised its holdings in shares of Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after purchasing an additional 187 shares during the period. Elevation Wealth Partners LLC lifted its stake in Cooper Companies by 1,136.4% in the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 375 shares during the last quarter. Finally, J.Safra Asset Management Corp purchased a new position in Cooper Companies in the second quarter valued at approximately $32,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO opened at $72.68 on Thursday. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The stock’s 50-day simple moving average is $72.36 and its 200 day simple moving average is $70.96. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The stock has a market capitalization of $14.17 billion, a price-to-earnings ratio of 61.59, a price-to-earnings-growth ratio of 1.91 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the previous year, the firm earned $0.96 EPS. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analysts Set New Price Targets

COO has been the subject of a number of recent research reports. Stifel Nicolaus decreased their target price on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. JPMorgan Chase & Co. dropped their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research report on Friday, June 5th. Wells Fargo & Company reiterated a “sell” rating and set a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. Finally, Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research note on Sunday, June 21st. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.